Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
Authors
Posts by Giuliana Miglierini
Giuliana Miglierini
130 POSTS
0 COMMENTS
The impact of falsified medicines
Giuliana Miglierini
-
17 April 2020
0
The Netherlands: Innovation in the academia and the industry
Giuliana Miglierini
-
26 March 2020
0
The impact of Covid-19 on drug shortages
Giuliana Miglierini
-
26 March 2020
0
Time to innovate the EU variation system
Giuliana Miglierini
-
26 March 2020
0
A new virus looking for effective treatments
Giuliana Miglierini
-
26 March 2020
0
Affordability and innovation for sustainable access to medicines
Giuliana Miglierini
-
20 February 2020
0
The principles to develop ePI
Giuliana Miglierini
-
20 February 2020
0
The MDCG’s guideline on the cybersecurity of medical devices
Giuliana Miglierini
-
20 February 2020
0
Lithuania: The status of HTA in Lithuania
Giuliana Miglierini
-
20 February 2020
0
Norway: Initiative to lower drug prices in nine European Countries
Giuliana Miglierini
-
21 January 2020
0
1
2
3
...
13
Page 2 of 13
